1. Borghans JAM, Keşmir C, et al. Flower D, Timmis J, editors. 2007. MHC diversity in individuals and populations. In silico immunology. Springer;Boston, MA: p. 177–95. DOI:
10.1007/978-0-387-39241-7_10.
Article
2. Cao K, Chopek M, Fernández-Viña MA. 1999; High and intermediate resolution DNA typing systems for class I HLA-A, B, C genes by hybridization with sequence-specific oligonucleotide probes (SSOP). Rev Immunogenet. 1:177–208. PMID:
11253946.
3. Olerup O, Zetterquist H. 1992; HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens. 39:225–35. DOI:
10.1111/j.1399-0039.1992.tb01940.x. PMID:
1357775.
Article
4. Saiki RK, Walsh PS, Levenson CH, Erlich HA. 1989; Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes. Proc Natl Acad Sci U S A. 86:6230–4. DOI:
10.1073/pnas.86.16.6230. PMID:
2762325. PMCID:
PMC297811.
Article
5. Lind C, Ferriola D, Mackiewicz K, Heron S, Rogers M, Slavich L, et al. 2010; Next-generation sequencing: the solution for high-resolution, unambiguous human leukocyte antigen typing. Hum Immunol. 71:1033–42. DOI:
10.1016/j.humimm.2010.06.016. PMID:
20603174.
Article
9. Shiina T, Suzuki S, Ozaki Y, Taira H, Kikkawa E, Shigenari A, et al. 2012; Super high resolution for single molecule-sequence-based typing of classical HLA loci at the 8-digit level using next generation sequencers. Tissue Antigens. 80:305–16. DOI:
10.1111/j.1399-0039.2012.01941.x. PMID:
22861646.
Article
11. Ehrenberg PK, Geretz A, Baldwin KM, Apps R, Polonis VR, Robb ML, et al. 2014; High-throughput multiplex HLA genotyping by next-generation sequencing using multi-locus individual tagging. BMC Genomics. 15:864. DOI:
10.1186/1471-2164-15-864. PMID:
25283548. PMCID:
PMC4196003.
Article
12. Jun JH, Hwang K, Kim SK, Oh HB, Cho MC, Lee KJ. 2014; Estimation of the 6-digit level allele and haplotype frequencies of HLA-A, −B, and -C in Koreans using ambiguity-solving DNA typing. Tissue Antigens. 84:277–84. DOI:
10.1111/tan.12368. PMID:
24851935.
Article
14. In JW, Roh EY, Oh S, Shin S, Park KU, Song EY. 2015; Allele and haplotype frequencies of Human Leukocyte Antigen-A, -B, -C, -DRB1, and -DQB1 from sequence-based DNA typing data in Koreans. Ann Lab Med. 35:429–35. DOI:
10.3343/alm.2015.35.4.429. PMID:
26131415. PMCID:
PMC4446582.
Article
15. Chung HY, Yoon JA, Han BY, Song EY, Park MH. 2010; Allelic and haplotypic diversity of HLA-A, -B, -C, and -DRB1 genes in Koreans defined by high-resolution DNA typing. Korean J Lab Med. 30:685–96. DOI:
10.3343/kjlm.2010.30.6.685. PMID:
21157157.
Article
16. Saito S, Ota S, Yamada E, Inoko H, Ota M. 2000; Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens. 56:522–9. DOI:
10.1034/j.1399-0039.2000.560606.x. PMID:
11169242.
Article
17. Kwok J, Guo M, Yang W, Lee CK, Ho J, Tang WH, et al. 2016; HLA-A, -B, -C, and -DRB1 genotyping and haplotype frequencies for a Hong Kong Chinese population of 7595 individuals. Hum Immunol. 77:1111–2. DOI:
10.1016/j.humimm.2016.10.005. PMID:
27769748.
Article
19. Alfirevic A, Gonzalez-Galarza F, Bell C, Martinsson K, Platt V, Bretland G, et al. 2012; In silico analysis of HLA associations with drug-induced liver injury: use of a HLA-genotyped DNA archive from healthy volunteers. Genome Med. 4:51. DOI:
10.1186/gm350. PMID:
22732016. PMCID:
PMC3698530.
Article
20. Hajeer AH, Al Balwi MA, Aytül Uyar F, Alhaidan Y, Alabdulrahman A, Al Abdulkareem I, et al. 2013; HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype frequencies in Saudis using next generation sequencing technique. Tissue Antigens. 82:252–8. DOI:
10.1111/tan.12200. PMID:
24461004.
Article
22. Cocco E, Meloni A, Murru MR, Corongiu D, Tranquilli S, Fadda E, et al. 2012; Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated alleles. PLoS One. 7:e41678. DOI:
10.1371/journal.pone.0041678. PMID:
22848563. PMCID:
PMC3404969.
Article
23. Thomas R, Apps R, Qi Y, Gao X, Male V, O'hUigin C, et al. 2009; HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet. 41:1290–4. DOI:
10.1038/ng.486. PMID:
19935663. PMCID:
PMC2887091.
Article
24. Dubois V, Tiercy JM, Labonne MP, Dormoy A, Gebuhrer L. 2004; A new HLA-B44 allele (B*44020102S) with a splicing mutation leading to a complete deletion of exon 5. Tissue Antigens. 63:173–80. DOI:
10.1111/j.1399-0039.2004.00134.x. PMID:
14705988.
Article
25. Elsner HA, Bernard G, Eiz-Vesper B, de Matteis M, Bernard A, Blasczyk R. 2002; Non-expression of HLA-A*2901102 N is caused by a nucleotide exchange in the mRNA splicing site at the beginning of intron 4. Tissue Antigens. 59:139–41. DOI:
10.1034/j.1399-0039.2002.590212.x. PMID:
12028543.
26. Laforet M, Froelich N, Parissiadis A, Bausinger H, Pfeiffer B, Tongio MM. 1997; An intronic mutation responsible for a low level of expression of an HLA-A*24 allele. Tissue Antigens. 50:340–6. DOI:
10.1111/j.1399-0039.1997.tb02884.x. PMID:
9349616.
Article
27. Tamouza R, El Kassar N, Schaeffer V, Carbonnelle E, Tatari Z, Marzais F, et al. 2000; A novel HLA-B*39 allele (HLA-B*3916) due to a rare mutation causing cryptic splice site activation. Hum Immunol. 61:467–73. DOI:
10.1016/S0198-8859(00)00108-7. PMID:
10773349.
Article